Pioneering New Horizons in Autoimmune Therapy
A Renowned Figure's Journey from CAR-T to Novel Biotech Ventures
For half a decade, Georg Schett, a German researcher, has been recognized for his groundbreaking work in autoimmune disease therapy. His research notably demonstrated the potential of CAR-T therapy to reconfigure patients' immune systems, establishing him as a leader in the field.
Transitioning from Established Expertise to Innovative Therapies
Following his significant contributions, Schett has served on numerous advisory boards for biotech startups. He is now embarking on a new chapter, co-founding a biotech firm that, surprisingly, will not immediately focus on CAR-T therapies. Instead, the company plans to concentrate on developing antibody-based treatments, signifying a fresh direction for his research and entrepreneurial endeavors.